{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:40:36Z","timestamp":1786632036658,"version":"build-2736575974"},"reference-count":16,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain &amp; Palliative Care Pharmacotherapy"],"DOI":"10.1080\/15360288.2026.2718825","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:50:46Z","timestamp":1786629046000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Zoledronic Acid for Bone Pain Relief in Cancer Patients with Bone Metastasis Receiving Low Dose Opioids and Nsaids: A Randomized Controlled Study"],"prefix":"10.1080","author":[{"given":"Attiqa","family":"Choudhary","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Critical Care, Government Medical College and Hospital","place":["Jammu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahida","family":"Aziz","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Critical Care, Government Medical College and Hospital","place":["Jammu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naine","family":"Badrala","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Critical Care, Government Medical College and Hospital","place":["Jammu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Critical Care, Government Medical College and Hospital","place":["Jammu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"275","article-title":"Efficacy of zoledronic acid in managing bone pain in metastatic breast cancer patients","volume":"13","author":"Patel S","year":"2020","unstructured":"Patel S, Smith D, Johnson J, et al. Efficacy of zoledronic acid in managing bone pain in metastatic breast cancer patients. J Pain Res. 2020;13:275\u201382.","journal-title":"J Pain Res"},{"issue":"2","key":"e_1_3_3_3_1","first-page":"34","article-title":"Zoledronic acid for the treatment of bone metastases: a systematic review","volume":"9","author":"Gupta R","year":"2018","unstructured":"Gupta R, Desai S, Patel A, et al. Zoledronic acid for the treatment of bone metastases: a systematic review. Cancer Ther. 2018;9(2):34\u201345.","journal-title":"Cancer Ther"},{"key":"e_1_3_3_4_1","first-page":"2103","article-title":"Zoledronic acid reduces skeletal complications in multiple myeloma","volume":"342","author":"Berenson JR","year":"2000","unstructured":"Berenson JR, Lichtenstein A, Lipton A, et al. Zoledronic acid reduces skeletal complications in multiple myeloma. N Engl J Med. 2000;342:2103\u201310.","journal-title":"N Engl J Med"},{"issue":"18","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Zoledronic acid and fracture risk in postmenopausal women with osteoporosis","volume":"356","author":"Black D","year":"2007","unstructured":"Black D, Cummings SR, Harris S, et al. Zoledronic acid and fracture risk in postmenopausal women with osteoporosis. N Engl J Med. 2007;356(18):1809\u201322.","journal-title":"N Engl J Med"},{"issue":"9","key":"e_1_3_3_6_1","first-page":"4250","article-title":"The role of zoledronic acid in managing pain from bone metastases in patients with advanced cancer","volume":"29","author":"Lipton A","year":"2011","unstructured":"Lipton A, Morley S, McGowan J, et al. The role of zoledronic acid in managing pain from bone metastases in patients with advanced cancer. J Clin Oncol. 2011;29(9):4250\u20139.","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_7_1","first-page":"4207","article-title":"Zoledronic acid for bone pain control in metastatic cancer: a randomized trial","volume":"23","author":"Henry D","year":"2005","unstructured":"Henry D, Zhang Z, Lang M, et al. Zoledronic acid for bone pain control in metastatic cancer: a randomized trial. J Clin Oncol. 2005;23:4207\u201313.","journal-title":"J Clin Oncol"},{"issue":"6","key":"e_1_3_3_8_1","first-page":"1061","article-title":"Zoledronic acid reduces opioid use in patients with metastatic cancer pain","volume":"37","author":"Lin S","year":"2009","unstructured":"Lin S, Harris C, Carter C, et al. Zoledronic acid reduces opioid use in patients with metastatic cancer pain. J Pain Symptom Manage. 2009;37(6):1061\u201370.","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"e_1_3_3_9_1","first-page":"1396","article-title":"Pain interference with daily living in patients with bone metastases: results from a randomized clinical trial","volume":"153","author":"Cohn AL","year":"2012","unstructured":"Cohn AL, Wong YN, Singh A, et al. Pain interference with daily living in patients with bone metastases: results from a randomized clinical trial. Pain. 2012;153(7):1396\u2013403.","journal-title":"Pain"},{"issue":"25","key":"e_1_3_3_10_1","first-page":"3099","article-title":"Zoledronic acid reduces skeletal-related events in metastatic breast cancer","volume":"31","author":"Santini D","year":"2013","unstructured":"Santini D, Bianchini G, Bini L, et al. Zoledronic acid reduces skeletal-related events in metastatic breast cancer. J Clin Oncol. 2013;31(25):3099\u2013105.","journal-title":"J Clin Oncol"},{"issue":"11","key":"e_1_3_3_11_1","first-page":"1671","article-title":"Zoledronic acid for the treatment of metastatic bone disease in patients with multiple myeloma: a systematic review","volume":"123","author":"Lipton A","year":"2014","unstructured":"Lipton A, Dispenzieri A, Lee J, et al. Zoledronic acid for the treatment of metastatic bone disease in patients with multiple myeloma: a systematic review. Blood. 2014;123(11):1671\u20137.","journal-title":"Blood"},{"issue":"5","key":"e_1_3_3_12_1","first-page":"894","article-title":"Kidney complications with bisphosphonates: a review of risks and management strategies","volume":"22","author":"Brown E","year":"2016","unstructured":"Brown E, Chin F, Chang S, et al. Kidney complications with bisphosphonates: a review of risks and management strategies. J Oncol Pharm Pract. 2016;22(5):894\u2013902.","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"e_1_3_3_13_1","first-page":"945","article-title":"Zoledronic acid and its renal toxicity in metastatic bone disease","volume":"30","author":"Rehman Z","year":"2015","unstructured":"Rehman Z, Shah J, Ali R, et al. Zoledronic acid and its renal toxicity in metastatic bone disease. J Bone Miner Res. 2015;30(6):945\u201350.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"e_1_3_3_14_1","first-page":"1514","article-title":"Bisphosphonate-related osteonecrosis of the jaw: risk factors, management strategies, and evolving treatment","volume":"32","author":"Ruggiero SL","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Assael LA, et al. Bisphosphonate-related osteonecrosis of the jaw: risk factors, management strategies, and evolving treatment. J Clin Oncol. 2014;32(9):1514\u201321.","journal-title":"J Clin Oncol"},{"issue":"3","key":"e_1_3_3_15_1","first-page":"213","article-title":"Zoledronic acid: a cost-effective strategy in managing metastatic bone disease","volume":"21","author":"Shah A","year":"2017","unstructured":"Shah A, Kaur A, Saluja M, et al. Zoledronic acid: a cost-effective strategy in managing metastatic bone disease. Cancer Econ. 2017;21(3):213\u20139.","journal-title":"Cancer Econ"},{"issue":"4","key":"e_1_3_3_16_1","first-page":"201","article-title":"The impact of skeletal-related events on the quality of life in metastatic bone disease","volume":"11","author":"Dreyer M","year":"2016","unstructured":"Dreyer M, Heher E, Markos S, et al. The impact of skeletal-related events on the quality of life in metastatic bone disease. J Cancer Pain. 2016;11(4):201\u20137.","journal-title":"J Cancer Pain"},{"issue":"2","key":"e_1_3_3_17_1","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland CS","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"}],"container-title":["Journal of Pain &amp; Palliative Care Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15360288.2026.2718825","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/15360288.2026.2718825","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15360288.2026.2718825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:50:48Z","timestamp":1786629048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15360288.2026.2718825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":16,"alternative-id":["10.1080\/15360288.2026.2718825"],"URL":"https:\/\/doi.org\/10.1080\/15360288.2026.2718825","relation":{},"ISSN":["1536-0288","1536-0539"],"issn-type":[{"value":"1536-0288","type":"print"},{"value":"1536-0539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}